NZ704247A - Compositions and treatment for eye diseases and disorders - Google Patents
Compositions and treatment for eye diseases and disordersInfo
- Publication number
- NZ704247A NZ704247A NZ704247A NZ70424713A NZ704247A NZ 704247 A NZ704247 A NZ 704247A NZ 704247 A NZ704247 A NZ 704247A NZ 70424713 A NZ70424713 A NZ 70424713A NZ 704247 A NZ704247 A NZ 704247A
- Authority
- NZ
- New Zealand
- Prior art keywords
- disorders
- compositions
- eye diseases
- treatment
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261676530P | 2012-07-27 | 2012-07-27 | |
| US201361756321P | 2013-01-24 | 2013-01-24 | |
| PCT/US2013/052264 WO2014018856A1 (en) | 2012-07-27 | 2013-07-26 | Compositions and treatment for eye diseases and disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ704247A true NZ704247A (en) | 2018-04-27 |
Family
ID=49997851
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ704247A NZ704247A (en) | 2012-07-27 | 2013-07-26 | Compositions and treatment for eye diseases and disorders |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US20150216877A1 (enExample) |
| EP (1) | EP2877184B1 (enExample) |
| JP (1) | JP6209777B2 (enExample) |
| KR (1) | KR102097663B1 (enExample) |
| CN (2) | CN104661663A (enExample) |
| AU (1) | AU2013295645B2 (enExample) |
| BR (1) | BR112015001847A8 (enExample) |
| CA (1) | CA2880027C (enExample) |
| DK (1) | DK2877184T3 (enExample) |
| ES (1) | ES2759781T3 (enExample) |
| HU (1) | HUE046963T2 (enExample) |
| IL (1) | IL236920B (enExample) |
| IN (1) | IN2015DN00542A (enExample) |
| MX (1) | MX362185B (enExample) |
| NZ (1) | NZ704247A (enExample) |
| PL (1) | PL2877184T3 (enExample) |
| PT (1) | PT2877184T (enExample) |
| SM (1) | SMT201900678T1 (enExample) |
| WO (1) | WO2014018856A1 (enExample) |
| ZA (1) | ZA201500561B (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| EP2782584B1 (en) | 2011-11-23 | 2021-06-09 | TherapeuticsMD, Inc. | Natural combination hormone replacement formulations and therapies |
| US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
| US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
| US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
| US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| EP2968368B1 (en) | 2013-03-15 | 2017-08-09 | Glia LLC | Cranial delivery of pharmaceuticals |
| WO2015080758A1 (en) * | 2013-11-27 | 2015-06-04 | Al-Qahtani Ahmed H | Method and composition for the treatment of moderate to severe keratoconjunctivitis sicca |
| AR100562A1 (es) | 2014-05-22 | 2016-10-12 | Therapeuticsmd Inc | Composición farmacéutica de estradiol y progesterona para terapia de reemplazo hormonal |
| CN106794168A (zh) | 2014-07-21 | 2017-05-31 | 格利亚有限责任公司 | 用大麻素治疗放疗和化疗相关的认知或情感损伤的方法 |
| KR20170040209A (ko) | 2014-07-29 | 2017-04-12 | 쎄러퓨틱스엠디, 인코퍼레이티드 | 경피 크림 |
| US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
| WO2017173044A1 (en) | 2016-04-01 | 2017-10-05 | Therapeuticsmd Inc. | Steroid hormone compositions in medium chain oils |
| KR20180126582A (ko) | 2016-04-01 | 2018-11-27 | 쎄러퓨틱스엠디, 인코퍼레이티드 | 스테로이드 호르몬 약제학적 조성물 |
| KR101960023B1 (ko) * | 2016-12-21 | 2019-03-20 | 김보경 | 이산화탄소 발생 장치 |
| US20230091716A1 (en) * | 2020-02-12 | 2023-03-23 | Glia, Llc | Progesterone Combinations |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5102656A (en) | 1983-07-29 | 1992-04-07 | The Mennen Company | Antiperspirant creams |
| US4937069A (en) | 1985-11-15 | 1990-06-26 | Bristol-Myers Squibb Company | Anhydrous semi-solid antiperspirant suspension |
| US5069897A (en) | 1987-10-16 | 1991-12-03 | The Proctor & Gamble Company | Antiperspirant creams |
| US6659985B2 (en) | 2002-01-30 | 2003-12-09 | Southern College Of Optometry | Method to use transdermal administration of androgens to the adnexa of the eye |
| US7572780B2 (en) * | 2003-01-21 | 2009-08-11 | Dimera, Incorporated | Method and kit for reducing the symptoms of peripheral vascular disease |
| US20080132475A1 (en) | 2006-12-05 | 2008-06-05 | Charles Gerald Connor | Treatment for dry eye |
| CA2702082A1 (en) * | 2007-10-08 | 2009-04-16 | Fovea Pharmaceuticals Sa | Aqueous ophthalmic formulations |
| US20100016264A1 (en) | 2007-12-05 | 2010-01-21 | Connor Charles G | Treatment for dry eye using testosterone and progestagen |
| CN101757622A (zh) * | 2008-11-28 | 2010-06-30 | 天津金耀集团有限公司 | 一种眼部抗炎的药物组合物 |
| AU2010302350B2 (en) * | 2009-10-02 | 2015-06-18 | Journey Medical Corporation | Surfactant-free water-free foamable compositions, breakable foams and gels and their uses |
-
2013
- 2013-07-26 WO PCT/US2013/052264 patent/WO2014018856A1/en not_active Ceased
- 2013-07-26 US US14/417,640 patent/US20150216877A1/en not_active Abandoned
- 2013-07-26 DK DK13823485T patent/DK2877184T3/da active
- 2013-07-26 JP JP2015524465A patent/JP6209777B2/ja active Active
- 2013-07-26 SM SM20190678T patent/SMT201900678T1/it unknown
- 2013-07-26 CN CN201380039713.2A patent/CN104661663A/zh active Pending
- 2013-07-26 PT PT138234851T patent/PT2877184T/pt unknown
- 2013-07-26 ES ES13823485T patent/ES2759781T3/es active Active
- 2013-07-26 CA CA2880027A patent/CA2880027C/en active Active
- 2013-07-26 HU HUE13823485A patent/HUE046963T2/hu unknown
- 2013-07-26 IN IN542DEN2015 patent/IN2015DN00542A/en unknown
- 2013-07-26 AU AU2013295645A patent/AU2013295645B2/en active Active
- 2013-07-26 NZ NZ704247A patent/NZ704247A/en unknown
- 2013-07-26 BR BR112015001847A patent/BR112015001847A8/pt not_active Application Discontinuation
- 2013-07-26 KR KR1020157004782A patent/KR102097663B1/ko active Active
- 2013-07-26 PL PL13823485T patent/PL2877184T3/pl unknown
- 2013-07-26 EP EP13823485.1A patent/EP2877184B1/en active Active
- 2013-07-26 CN CN201710063950.2A patent/CN107595857A/zh active Pending
- 2013-07-26 MX MX2015001250A patent/MX362185B/es active IP Right Grant
-
2015
- 2015-01-25 IL IL236920A patent/IL236920B/en active IP Right Grant
- 2015-01-26 ZA ZA2015/00561A patent/ZA201500561B/en unknown
-
2016
- 2016-12-15 US US15/380,741 patent/US9925201B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| BR112015001847A2 (pt) | 2017-07-04 |
| KR102097663B1 (ko) | 2020-04-06 |
| US20150216877A1 (en) | 2015-08-06 |
| JP2015524434A (ja) | 2015-08-24 |
| CA2880027C (en) | 2021-12-07 |
| CA2880027A1 (en) | 2014-01-30 |
| MX2015001250A (es) | 2015-10-22 |
| PT2877184T (pt) | 2019-12-02 |
| EP2877184A1 (en) | 2015-06-03 |
| EP2877184B1 (en) | 2019-09-04 |
| IL236920B (en) | 2018-06-28 |
| AU2013295645B2 (en) | 2017-08-24 |
| SMT201900678T1 (it) | 2020-03-13 |
| ES2759781T3 (es) | 2020-05-12 |
| US20170189413A1 (en) | 2017-07-06 |
| AU2013295645A1 (en) | 2015-02-05 |
| KR20150038311A (ko) | 2015-04-08 |
| MX362185B (es) | 2019-01-08 |
| EP2877184A4 (en) | 2016-03-30 |
| JP6209777B2 (ja) | 2017-10-11 |
| HK1210968A1 (en) | 2016-05-13 |
| CN107595857A (zh) | 2018-01-19 |
| HUE046963T2 (hu) | 2020-04-28 |
| CN104661663A (zh) | 2015-05-27 |
| ZA201500561B (en) | 2016-04-28 |
| US9925201B2 (en) | 2018-03-27 |
| IN2015DN00542A (enExample) | 2015-06-26 |
| BR112015001847A8 (pt) | 2021-09-08 |
| WO2014018856A1 (en) | 2014-01-30 |
| DK2877184T3 (da) | 2019-12-09 |
| PL2877184T3 (pl) | 2020-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX362185B (es) | Composiciones y tratamiento para enfermedades y trastornos del ojo. | |
| UA114705C2 (uk) | Андрогенна композиція для лікування офтальмологічного захворювання | |
| MY171920A (en) | Prevention and treatment of ocular conditions | |
| HK1258588A1 (zh) | 用於治疗眼科疾病的化合物和制剂 | |
| BR112015018438A2 (pt) | anticorpo contra c5 e método para prevenir e tratar doenças relacionadas a complemento | |
| PH12014502449A1 (en) | Methods for the treatment of diabetic retinopathy and other ophthalmic diseases | |
| MX2015012653A (es) | Formulaciones oculares para suministro de farmaco al segmento porterior del ojo. | |
| EA201590654A1 (ru) | Комбинация разагилина и придопидина для лечения нейродегенеративных нарушений, в частности болезни хантингтона | |
| MX361858B (es) | Formulación oftálmica de lípido polioxilo o de ácido graso polioxilo y tratamiento de padecimientos oculares. | |
| MY181828A (en) | Bicyclically substituted uracils and the use therapy | |
| MY170198A (en) | Agent for treatment of dry eye characterized by combining p2y2 receptor agonist and hyaluronic acid or salt thereof, method for treating dry eye, and use of the p2y2 receptor agonist and hyaluronic acid or salt thereof | |
| WO2012080497A3 (en) | Use of lp-pla2 inhibitors in the treatment and prevention of eye diseases | |
| DK2714888T3 (da) | Rekombinant gær | |
| EP4420722A3 (en) | Modified fibroblast growth factors for the treatment of ocular disorders | |
| NZ704178A (en) | Difluorolactam compounds as ep4 receptor-selective agonists for use in the treatment of ep4-mediated diseases and conditions | |
| MX2016000294A (es) | Composicion farmaceutica para liberacion sostenida de lanreotida. | |
| WO2014082738A8 (en) | Heteroquinoline-3-carboxamides as kcnq2/3 modulators | |
| MX359686B (es) | Formulaciones de nanoparticulas de polionasol líquidas y en gel. | |
| ZA202003944B (en) | Ophthalmic topical composition comprising dobesilic acid for treating diseases of the posterior segment of the eye | |
| PH12015501538A1 (en) | Topical ocular analgesic agents | |
| HK1219654A1 (zh) | 用於治疗眼科疾病和病症的方法 | |
| BR112015007095A2 (pt) | derivados de di-hidro-6-azafenaleno para o tratamento de doenças do snc, oncológicas e distúrbios relacionados | |
| MX358072B (es) | Composiciones tópicas que comprenden diaminooxidasa para el tratamiento o la prevención de enfermedades asociadas a un nivel de histamina elevada que involucran un aumento del dolor. | |
| PH12015500852A1 (en) | Method for treating eye disorders | |
| MX2015004806A (es) | Composiciones y metodos para el tratamiento de la enfermedad de parkinson. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ASS | Change of ownership |
Owner name: GLIA LLC, US Effective date: 20170821 |
|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 JUL 2020 BY COMPUTER PACKAGES INC Effective date: 20190718 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 JUL 2021 BY COMPUTER PACKAGES INC Effective date: 20200701 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 JUL 2022 BY COMPUTER PACKAGES INC Effective date: 20210630 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 JUL 2023 BY COMPUTER PACKAGES INC Effective date: 20220717 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 JUL 2024 BY COMPUTER PACKAGES INC Effective date: 20230630 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 JUL 2025 BY COMPUTER PACKAGES INC Effective date: 20250101 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 JUL 2026 BY COMPUTER PACKAGES INC Effective date: 20250930 |